CARGO Therapeutics
phase was generally well tolerated | CARGO Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
14 of 29
Related slides by other companies
CG Oncology
IPO
March 2024
has been generally well tolerated with no grade or higher treatment related aes | CG Oncology
AN2 Therapeutics
Investor Presentation
February 2025
appears generally well tolerated in phase trial | AN2 Therapeutics
AN2 Therapeutics
Investor Presentation
March 2025
appears generally well tolerated in phase trial | AN2 Therapeutics
Larimar Therapeutics
Investor Presentation
November 2023
appeared to be generally well tolerated in phase trial cohort | Larimar Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights